Arcturus Therapeutics, Inc.
Doing business as Arcturus Therapeutics Inc.
- UEI
- E3MFDBN4L3J9
- CAGE
- 6X1L5
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Website
- arcturusrx.com
- Founded
- 2013
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Procure a pandemic influenza vaccine (pandflu) and a quadrivalent seasonal influenza vaccine (qsflu) | Office of the Assistant Secretary for Preparedness and Response | $63,239,785 |
Quick answers
What is Arcturus Therapeutics, Inc.'s UEI?
Arcturus Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is E3MFDBN4L3J9.
What is Arcturus Therapeutics, Inc.'s CAGE code?
Arcturus Therapeutics, Inc.'s CAGE code is 6X1L5.
What is Arcturus Therapeutics, Inc.'s primary NAICS code?
Arcturus Therapeutics, Inc.'s primary NAICS code is 325414 (Biological Product (except Diagnostic) Manufacturing).
Is Arcturus Therapeutics, Inc. registered in SAM.gov?
Arcturus Therapeutics, Inc.'s SAM.gov registration expired on December 10, 2025.
What is Arcturus Therapeutics, Inc.'s most recent federal award?
Arcturus Therapeutics, Inc.'s most recent federal contract award is Procure a pandemic influenza vaccine (pandflu) and a quadrivalent seasonal influenza vaccine (qsflu) (75A50122C00007), from Office of the Assistant Secretary for Preparedness and Response, on September 1, 2022.
On GovTribe
See Arcturus Therapeutics, Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors